TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240245784A1
SERIAL NO

18409330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides conjugates that comprise a targeting moiety, a nucleic acid, and optional linking groups as well as synthetic intermediates and synthetic methods useful for preparing the conjugates. The conjugates are useful to target therapeutic nucleic acids to the liver and to treat liver diseases including hepatitis (e.g. hepatitis B and hepatitis D).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARBUTUS BIOPHARMA CORPORATION100-8900 GLENLYON PARKWAY BURNABY BRITISH COLUMBIA V5J 5J8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HEYES, James Vancouver, CA 67 4027
HOLLAND, Richard J Vancouver, CA 41 499
MARTIN, Alan D Vancouver, CA 20 994
WOOD, Mark Port Moody, CA 123 2599

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation